• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未经治疗的原发性肺癌和乳腺癌:F-18 FDG动力学速率常数与体外研究结果的相关性

Untreated primary lung and breast cancers: correlation between F-18 FDG kinetic rate constants and findings of in vitro studies.

作者信息

Torizuka T, Zasadny K R, Recker B, Wahl R L

机构信息

Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0028, USA.

出版信息

Radiology. 1998 Jun;207(3):767-74. doi: 10.1148/radiology.207.3.9609902.

DOI:10.1148/radiology.207.3.9609902
PMID:9609902
Abstract

PURPOSE

To compare kinetic modeling of 2-[fluorine-18]fluoro-2-deoxy-D-glucose (F-18 FDG) between untreated primary lung and untreated primary breast cancers by using positron emission tomographic (PET) findings and to correlate these findings with findings of in vitro studies.

MATERIALS AND METHODS

Nineteen patients (12 men, seven women; age range, 49-82 years) with untreated primary lung cancer and 17 women with untreated primary breast cancer (age range, 26-65 years) underwent 1-hour dynamic F-18 FDG PET. A three-compartment model was applied to F-18 FDG kinetics in tumors. The standard uptake value normalized for lean body mass (SUVlean) in tumors was measured 50-60 minutes after tracer injection. In vitro, thin-layer chromatography was performed to evaluate the intracellular phosphorylation of tritiated F-18 FDG in human lung cancer and breast cancer cell lines.

RESULTS

At PET, lung cancer had a significantly (P < .003) higher rate constant for F-18 FDG phosphorylation (k3) and SUVlean than did breast cancer (0.164 +/- 0.150 [standard deviation] vs 0.043 +/- 0.018 and 8.25 +/- 3.28 vs 3.17 +/- 1.08, respectively). Breast cancer showed a significant correlation between k3 and SUVlean (r = .607, P < .01), although no such correlation was observed in lung cancer. In vitro studies showed phosphorylation of F-18 FDG in breast cancer cells was less complete in hyperglycemia than it was in lung cancer cells.

CONCLUSION

A much lower k3 appears to be a rate-limiting factor for F-18 FDG accumulation in breast cancer, while the higher k3 in lung cancer is probably not rate limiting for F-18 FDG accumulation.

摘要

目的

通过正电子发射断层扫描(PET)结果比较未经治疗的原发性肺癌和未经治疗的原发性乳腺癌中2-[氟-18]氟-2-脱氧-D-葡萄糖(F-18 FDG)的动力学模型,并将这些结果与体外研究结果相关联。

材料与方法

19例未经治疗的原发性肺癌患者(12例男性,7例女性;年龄范围49 - 82岁)和17例未经治疗的原发性乳腺癌女性患者(年龄范围26 - 65岁)接受了1小时的动态F-18 FDG PET检查。将三室模型应用于肿瘤中F-18 FDG的动力学研究。在示踪剂注射后50 - 60分钟测量肿瘤中瘦体重标准化的标准摄取值(SUVlean)。在体外,进行薄层色谱法评估人肺癌和乳腺癌细胞系中氚标记的F-18 FDG的细胞内磷酸化情况。

结果

在PET检查中,肺癌的F-18 FDG磷酸化速率常数(k3)和SUVlean显著高于乳腺癌(P <.003)(分别为0.164±0.150[标准差]对0.043±0.018,以及8.25±3.28对3.17±1.08)。乳腺癌的k3与SUVlean之间存在显著相关性(r =.607,P <.01),而在肺癌中未观察到这种相关性。体外研究表明,高血糖状态下乳腺癌细胞中F-18 FDG的磷酸化不如肺癌细胞完全。

结论

较低的k3似乎是F-18 FDG在乳腺癌中蓄积的限速因素,而肺癌中较高的k3可能不是F-18 FDG蓄积的限速因素。

相似文献

1
Untreated primary lung and breast cancers: correlation between F-18 FDG kinetic rate constants and findings of in vitro studies.未经治疗的原发性肺癌和乳腺癌:F-18 FDG动力学速率常数与体外研究结果的相关性
Radiology. 1998 Jun;207(3):767-74. doi: 10.1148/radiology.207.3.9609902.
2
Quantitative assessment of heterogeneity in tumor metabolism using FDG-PET.使用 FDG-PET 对肿瘤代谢的异质性进行定量评估。
Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):e725-31. doi: 10.1016/j.ijrobp.2011.11.039. Epub 2012 Feb 11.
3
Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET.
Radiology. 1995 Jul;196(1):167-73. doi: 10.1148/radiology.196.1.7784562.
4
Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling.生殖细胞肿瘤:利用氟代脱氧葡萄糖正电子发射断层扫描(FDG PET)和动力学模型鉴别存活肿瘤、成熟畸胎瘤及坏死组织。
Radiology. 1999 Apr;211(1):249-56. doi: 10.1148/radiology.211.1.r99ap16249.
5
Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer.未经治疗的原发性人类非小细胞肺癌中的葡萄糖转运蛋白与氟代脱氧葡萄糖摄取
J Nucl Med. 1999 Apr;40(4):556-65.
6
Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.6-脱氧-6-[18F]氟-D-果糖作为乳腺癌 GLUT5 PET 成像示踪剂的放射药理学评价。
Nucl Med Biol. 2011 May;38(4):461-75. doi: 10.1016/j.nucmedbio.2010.11.004. Epub 2011 Feb 4.
7
Measuring [(18)F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods.化疗期间测量乳腺癌中[18F]氟代脱氧葡萄糖摄取:分析方法的比较
Eur J Nucl Med Mol Imaging. 2003 May;30(5):674-81. doi: 10.1007/s00259-003-1127-z. Epub 2003 Mar 15.
8
SUV varies with time after injection in (18)F-FDG PET of breast cancer: characterization and method to adjust for time differences.在乳腺癌的(18)F-FDG PET检查中,标准摄取值(SUV)随注射后时间而变化:特征描述及针对时间差异进行调整的方法。
J Nucl Med. 2003 Jul;44(7):1044-50.
9
Short dynamic FDG-PET imaging protocol for patients with lung cancer.用于肺癌患者的短动态氟代脱氧葡萄糖正电子发射断层显像成像方案
Eur J Nucl Med. 2000 Oct;27(10):1538-42. doi: 10.1007/s002590000312.
10
Effects of DNA ploidy and S-phase fraction on fluorine-18 FDG uptake of primary breast cancer lesions.原发性乳腺癌病灶摄取氟-18 氟脱氧葡萄糖与 DNA 倍体和 S 期分数的关系。
Clin Breast Cancer. 2013 Jun;13(3):196-201. doi: 10.1016/j.clbc.2012.09.010. Epub 2012 Oct 17.

引用本文的文献

1
Clinical PET-MR Imaging in Breast Cancer and Lung Cancer.乳腺癌和肺癌的临床正电子发射断层扫描-磁共振成像
PET Clin. 2016 Oct;11(4):387-402. doi: 10.1016/j.cpet.2016.05.008.
2
Single-Cell Analysis of [18F]Fluorodeoxyglucose Uptake by Droplet Radiofluidics.通过液滴放射流体技术对[18F]氟脱氧葡萄糖摄取进行单细胞分析。
Anal Chem. 2015 Jul 7;87(13):6667-73. doi: 10.1021/acs.analchem.5b00792. Epub 2015 Jun 15.
3
Prognostic Value of Fluoro-D-glucose Uptake of Primary Tumor and Metastatic Lesions in Advanced Nonsmall Cell Lung Cancer.氟代脱氧葡萄糖摄取在晚期非小细胞肺癌原发肿瘤及转移灶中的预后价值
World J Nucl Med. 2014 May;13(2):112-9. doi: 10.4103/1450-1147.139142.
4
Use of benzodiazepines before (18)F-FDG-PET/CT dual-phase imaging does not decrease the efficacy of the study.在进行(18)F-FDG-PET/CT双期成像之前使用苯二氮䓬类药物不会降低研究的有效性。
Indian J Nucl Med. 2012 Jan;27(1):24-9. doi: 10.4103/0972-3919.108838.
5
The Potential Benefit by Application of Kinetic Analysis of PET in the Clinical Oncology.正电子发射断层扫描(PET)动力学分析在临床肿瘤学中的应用潜在益处
ISRN Oncol. 2012;2012:349351. doi: 10.5402/2012/349351. Epub 2012 Dec 26.
6
Importance of quantification for the analysis of PET data in oncology: review of current methods and trends for the future.肿瘤 PET 数据分析中定量的重要性:当前方法综述及未来趋势。
Mol Imaging Biol. 2012 Apr;14(2):131-46. doi: 10.1007/s11307-011-0514-2.
7
An exploratory pilot study into the association between microcirculatory parameters derived by MRI-based pharmacokinetic analysis and glucose utilization estimated by PET-CT imaging in head and neck cancer.基于 MRI 药代动力学分析的微循环参数与 PET-CT 成像估计的头颈部癌症葡萄糖利用之间关联的探索性初步研究。
Eur Radiol. 2010 Oct;20(10):2358-66. doi: 10.1007/s00330-010-1803-x. Epub 2010 May 5.
8
Volume-normalized uptake rates with robust transportability from PET dual-time and Patlak analyses.容积标准化摄取率,具有从 PET 双时相和 Patlak 分析中得到的稳健可转移性。
Mol Imaging Biol. 2010 Oct;12(5):479-87. doi: 10.1007/s11307-009-0280-6. Epub 2009 Dec 1.
9
Dual-time-point FDG-PET/CT for the detection of hepatic metastases.双时相FDG-PET/CT用于检测肝转移瘤。
Mol Imaging Biol. 2008 Nov-Dec;10(6):335-40. doi: 10.1007/s11307-008-0159-y. Epub 2008 Aug 16.
10
Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography.使用[18F]-2-氟-2-脱氧-D-葡萄糖正电子发射断层扫描比较胆管细胞癌中葡萄糖转运蛋白和己糖激酶II的表达。
Cancer Sci. 2008 Feb;99(2):260-6. doi: 10.1111/j.1349-7006.2007.00683.x.